Remifentanil in emergency caesarean section in pre-eclampsia complicated by thrombocytopenia and abnormal liver function.
We describe the use of remifentanil in a woman with severe pre-eclampsia who presented for emergency caesarean section. Remifentanil was effective in obtunding the hypertensive response to laryngoscopy and intubation. Previous studies have found no significant adverse effects of remifentanil on the neonate. With its short duration of action, the use of this new opioid has several potential advantages in the above setting. Further studies are required to explore the use of remifentanil as an adjunct to obstetric general anaesthesia.
Johannsen
E K
EK
Department of Anaesthesia, Waikato Hospital, Hamilton, New Zealand.
Munro
A J
AJ
D000328:Adult; D000701:Analgesics, Opioid; D000768:Anesthesia, General; D000773:Anesthesia, Obstetrical; D002585:Cesarean Section; D004630:Emergencies; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control; D007442:Intubation, Intratracheal / Q000009:adverse effects; D008099:Liver / Q000503:physiopathology*; D010880:Piperidines; D011225:Pre-Eclampsia / Q000150:complications*; D011247:Pregnancy; D011248:Pregnancy Complications; D000077208:Remifentanil; D013921:Thrombocytopenia / Q000150:complications*
D000701:Analgesics, Opioid; D010880:Piperidines; D000077208:Remifentanil